Evexia Lifecare Limited (BOM:524444)
India · Delayed Price · Currency is INR 1.650
+0.020 (1.23%)
At close: Jan 22, 2026
Evexia Lifecare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 1,113 | 1,105 | 562.7 | 695.53 | 755.13 | 1,066 | Upgrade |
Other Revenue | - | - | - | - | 0 | - | Upgrade |
| 1,113 | 1,105 | 562.7 | 695.53 | 755.13 | 1,066 | Upgrade | |
Revenue Growth (YoY) | 37.75% | 96.35% | -19.10% | -7.89% | -29.18% | 6.42% | Upgrade |
Cost of Revenue | 893.93 | 888.42 | 506.88 | 656.67 | 707.85 | 1,030 | Upgrade |
Gross Profit | 219.03 | 216.42 | 55.81 | 38.85 | 47.29 | 36.51 | Upgrade |
Selling, General & Admin | 59.37 | 57.78 | 9.49 | 11.45 | 5.82 | 5.86 | Upgrade |
Other Operating Expenses | 125.18 | 117.89 | 19.74 | 21.56 | 17.29 | 732.36 | Upgrade |
Operating Expenses | 201.82 | 192.63 | 40.48 | 36.94 | 25.18 | 740.63 | Upgrade |
Operating Income | 17.22 | 23.79 | 15.34 | 1.91 | 22.11 | -704.13 | Upgrade |
Interest Expense | -10.95 | -10.87 | -4.84 | -5.35 | -0.96 | -0.05 | Upgrade |
Interest & Investment Income | - | - | 7.66 | 12.34 | 0.33 | 0.47 | Upgrade |
Currency Exchange Gain (Loss) | - | - | 1.21 | 0.91 | - | - | Upgrade |
Other Non Operating Income (Expenses) | 5.75 | 1.44 | -0.08 | 5.49 | 0.28 | 723.39 | Upgrade |
EBT Excluding Unusual Items | 12.02 | 14.37 | 19.29 | 15.3 | 21.76 | 19.69 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.47 | Upgrade |
Pretax Income | 12.02 | 14.37 | 19.29 | 15.3 | 21.76 | 19.22 | Upgrade |
Income Tax Expense | 8.66 | 5.06 | 5.52 | 8.63 | 13.14 | 6.39 | Upgrade |
Net Income | 3.36 | 9.3 | 13.77 | 6.67 | 8.62 | 12.83 | Upgrade |
Net Income to Common | 3.36 | 9.3 | 13.77 | 6.67 | 8.62 | 12.83 | Upgrade |
Net Income Growth | -90.94% | -32.43% | 106.53% | -22.66% | -32.79% | -63.03% | Upgrade |
Shares Outstanding (Basic) | 1,034 | 930 | 708 | 664 | 619 | 619 | Upgrade |
Shares Outstanding (Diluted) | 1,034 | 930 | 708 | 664 | 619 | 619 | Upgrade |
Shares Change (YoY) | 47.76% | 31.41% | 6.56% | 7.28% | - | - | Upgrade |
EPS (Basic) | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | Upgrade |
EPS (Diluted) | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | Upgrade |
EPS Growth | -93.87% | -48.58% | 94.49% | -28.16% | -30.41% | -64.28% | Upgrade |
Free Cash Flow | -2,208 | -67.46 | 167.62 | -55.93 | -82.26 | 15.16 | Upgrade |
Free Cash Flow Per Share | -2.14 | -0.07 | 0.24 | -0.08 | -0.13 | 0.02 | Upgrade |
Gross Margin | 19.68% | 19.59% | 9.92% | 5.59% | 6.26% | 3.42% | Upgrade |
Operating Margin | 1.55% | 2.15% | 2.73% | 0.27% | 2.93% | -66.04% | Upgrade |
Profit Margin | 0.30% | 0.84% | 2.45% | 0.96% | 1.14% | 1.20% | Upgrade |
Free Cash Flow Margin | -198.41% | -6.11% | 29.79% | -8.04% | -10.89% | 1.42% | Upgrade |
EBITDA | 34.49 | 40.75 | 19.5 | 5.84 | 24.18 | -701.71 | Upgrade |
EBITDA Margin | 3.10% | 3.69% | 3.46% | 0.84% | 3.20% | -65.81% | Upgrade |
D&A For EBITDA | 17.27 | 16.96 | 4.16 | 3.93 | 2.08 | 2.42 | Upgrade |
EBIT | 17.22 | 23.79 | 15.34 | 1.91 | 22.11 | -704.13 | Upgrade |
EBIT Margin | 1.55% | 2.15% | 2.73% | 0.27% | 2.93% | -66.04% | Upgrade |
Effective Tax Rate | 72.03% | 35.23% | 28.62% | 56.41% | 60.38% | 33.26% | Upgrade |
Revenue as Reported | 12.44 | - | 571.55 | 714.31 | 755.79 | 1,810 | Upgrade |
Advertising Expenses | - | - | 0.05 | 0.04 | 0.68 | 0.11 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.